Is HLS Therapeutics Inc. (HLTRF) a Buy, Sell, or Hold?
OTC : HLTRF
HLS Therapeutics Inc. — News
$2.9 USD
-$0.08 (-2.68%)
- Volume
- 100
- Average Volume
- 190
- Market Capitalization
- $90.7M
- P/E Ratio
- -9.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $4.02
- Year Low
- $2.90
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.00
| Source | Headline |
|---|---|
|
HLS Therapeutics Q1 Earnings Call Highlights
HLS Therapeutics TSE: HLS reported modest first-quarter revenue growth and reaffirmed its 2026 outlook, while management highlighted early momentum for the company's newly launched cholesterol drug NILEMDO and continued deleveraging of its balance sheet. marketbeat.com - 2026-05-16 08:07:13 |
